AzTrials
AzTrials

Post Operative AdhesionsPhase 3HiBNCT02790177

Role of Hyaluronic Acid in the Prevention of Post-operative Adhesions: a RCT

A Phase 3 study testing Hyaluronic Acid and NORMAL SALINE in people with Post Operative Adhesions, run by Services Institute of Medical Sciences, Pakistan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The objective of study is to determine the effect of hyaluronic acid on the formation of post-operative adhesions. It will be a randomized control trial comparing the product against normal saline. Read more about this study

Who is it for?
Ages 12 years and older
Conditions the study is for
Post Operative Adhesions
What is being tested?
Hyaluronic Acid and NORMAL SALINE
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
150 participants
Where
No sites listed yet
Study dates
Jun 2016to Dec 2017
Phase
Phase 3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • All consenting patients between the ages of 12-80, who undergo exploratory laparotomy and stoma formation

Who cannot join

  • Previous history of abdominal surgery History of peritoneal dialysis Patients in whom permanent stoma is formed
  • -

About this study

Official title: Is Hyaluronic Acid Effective in the Prevention of Post-operative Adhesion?

The objective of study is to determine the effect of hyaluronic acid on the formation of post-operative adhesions. It will be a randomized control trial comparing the product against normal saline.

Being tested
Hyaluronic Acid, NORMAL SALINE

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hyaluronic AcidDrug

  • NORMAL SALINEDrug

Study groups in NCT02790177
Study groupRoleWhat they receive
HiBExperimentalThis group will receive the compound for the reduction of adhesions
Receives: Drug: Hyaluronic Acid
Normal salinePlacebo comparatorThis group will just receive normal saline to ensure blinding.
Receives: Drug: NORMAL SALINE

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. POST OPERATIVE ADHESIONS TO BE EVALUATED BY LAPAROSCOPY AT THREE MONTHS INTERVAL

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jun 2016 (estimated)
  2. Study startJun 2016
  3. Primary completionMay 2017 (estimated)
  4. Study completionDec 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02790177
Sponsor's protocol ID
ServicesIMSP
Acronym
HiB
Status last verified
May 2016
First submitted
23 May 2016
Last updated
3 Jun 2016
Results posted
No
Data monitoring committee
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing Hyaluronic Acid and NORMAL SALINE in people with Post Operative Adhesions, run by Services Institute of Medical Sciences, Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 3 Jun 2016. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

POST OPERATIVE ADHESIONS TO BE EVALUATED BY LAPAROSCOPY AT THREE MONTHS INTERVAL (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jun 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in